Skip to main content

Advertisement

Log in

Bridging the Gaps in the Care of Psoriasis and Psoriatic Arthritis: the Role of Combined Clinics

Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Despite a robust therapeutic landscape, significant gaps exist in the quality of care of psoriatic disease. Thus, an improved understanding of the challenges in providing quality care and the implementation of effective strategies to overcome them is needed. In this review, we summarize the burden of psoriatic disease, discuss the challenges in the care of psoriatic patients, and outline how combined dermatology-rheumatology clinics bridge many of these gaps.

Recent Findings

Multiple challenges are faced in providing high-quality care to patients with psoriasis and psoriatic arthritis from the pre-diagnosis phase of disease to the follow-up period. Challenges are mainly driven by lack of education of patients and healthcare providers, inefficient communication between specialists, lack of a holistic approach to patients, and limitations of available therapies. The Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network (PPACMAN) is working on demonstrating the effectiveness of combined dermatology-rheumatology clinics in addressing some of these challenges. Recent findings show that combined clinic models may improve quality of care by raising awareness of psoriatic disease, fostering educational activities for both patients and physicians, and allowing for comprehensive evaluation and management of patients through improved communications between disciplines.

Summary

Psoriasis and psoriatic arthritis are complex diseases that often require an interdisciplinary approach. Thus, combined dermatology-rheumatology clinics and local-regional partnerships are potentially effective in improving quality of care in psoriatic disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70(3):512–6. https://doi.org/10.1016/j.jaad.2013.11.013.

    Article  PubMed  Google Scholar 

  2. Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol. 2009;60(2):218–24. https://doi.org/10.1016/j.jaad.2008.09.022.

    Article  PubMed  Google Scholar 

  3. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Identification, management of P et al. global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Investig Dermatol. 2013;133(2):377–85. https://doi.org/10.1038/jid.2012.339.

    Article  CAS  PubMed  Google Scholar 

  4. Reich K, Kruger K, Mossner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol. 2009;160(5):1040–7. https://doi.org/10.1111/j.1365-2133.2008.09023.x.

    Article  CAS  PubMed  Google Scholar 

  5. • Ogdie A, Weiss P. The epidemiology of psoriatic arthritis. Rheum Dis Clin N Am. 2015;41(4):545–68. https://doi.org/10.1016/j.rdc.2015.07.001 Overview on the epidemiology of psoriatic arthritis.

    Article  Google Scholar 

  6. Christophers E, Barker JN, Griffiths CE, Dauden E, Milligan G, Molta C, et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol. 2010;24(5):548–54. https://doi.org/10.1111/j.1468-3083.2009.03463.x.

    Article  CAS  PubMed  Google Scholar 

  7. Gottlieb AB, Mease PJ, Mark Jackson J, Eisen D, Amy Xia H, Asare C, et al. Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists’ offices. J Dermatol Treat. 2006;17(5):279–87. https://doi.org/10.1080/09546630600823369.

    Article  Google Scholar 

  8. Chang CA, Gottlieb AB, Lizzul PF. Management of psoriatic arthritis from the view of the dermatologist. Nat Rev Rheumatol. 2011;7(10):588–98. https://doi.org/10.1038/nrrheum.2011.125.

    Article  CAS  PubMed  Google Scholar 

  9. Kane D, Stafford L, Bresnihan B, FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford). 2003;42(12):1460–8. https://doi.org/10.1093/rheumatology/keg384.

    Article  CAS  Google Scholar 

  10. Gladman DD, Stafford-Brady F, Chang CH, Lewandowski K, Russell ML. Longitudinal study of clinical and radiological progression in psoriatic arthritis. J Rheumatol. 1990;17(6):809–12.

    CAS  PubMed  Google Scholar 

  11. Tezel N, Yilmaz Tasdelen O, Bodur H, Gul U, Kulcu Cakmak S, Oguz ID, et al. Is the health-related quality of life and functional status of patients with psoriatic arthritis worse than that of patients with psoriasis alone? Int J Rheum Dis. 2015;18(1):63–9. https://doi.org/10.1111/1756-185X.12283.

    Article  CAS  PubMed  Google Scholar 

  12. •• Armstrong AW, Siegel MP, Bagel J, Boh EE, Buell M, Cooper KD, et al. From the medical Board of the National Psoriasis Foundation: treatment targets for plaque psoriasis. J Am Acad Dermatol. 2017;76(2):290–8. https://doi.org/10.1016/j.jaad.2016.10.017 Study describing the current treatment trends in psoriasis and demonstrating the level of undertreatment in psoriatic disease.

    Article  PubMed  Google Scholar 

  13. Ghatnekar O, Ljungberg A, Wirestrand LE, Svensson A. Costs and quality of life for psoriatic patients at different degrees of severity in southern Sweden—a cross-sectional study. Eur J Dermatol. 2012;22(2):238–45. https://doi.org/10.1684/ejd.2011.1635.

    Article  PubMed  Google Scholar 

  14. Greenberg JD, Palmer JB, Li Y, Herrera V, Tsang Y, Liao M. Healthcare resource use and direct costs in patients with ankylosing spondylitis and psoriatic arthritis in a large US cohort. J Rheumatol. 2016;43(1):88–96. https://doi.org/10.3899/jrheum.150540.

    Article  PubMed  Google Scholar 

  15. Tillett W, Shaddick G, Askari A, Cooper A, Creamer P, Clunie G, et al. Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study. Rheumatology (Oxford). 2015;54(1):157–62. https://doi.org/10.1093/rheumatology/keu264.

    Article  Google Scholar 

  16. Boehncke WH, Menter A. Burden of disease: psoriasis and psoriatic arthritis. Am J Clin Dermatol. 2013;14(5):377–88. https://doi.org/10.1007/s40257-013-0032-x.

    Article  PubMed  Google Scholar 

  17. Helliwell P, Coates L, Chandran V, Gladman D, de Wit M, FitzGerald O, et al. Qualifying unmet needs and improving standards of care in psoriatic arthritis. Arthritis Care Res (Hoboken). 2014;66(12):1759–66. https://doi.org/10.1002/acr.22404.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Mease PJ, Gladman DD, Papp KA, Khraishi MM, Thaci D, Behrens F, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/north American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729–35. https://doi.org/10.1016/j.jaad.2013.07.023.

    Article  PubMed  Google Scholar 

  19. Haroon M, Kirby B, FitzGerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis. 2013;72(5):736–40. https://doi.org/10.1136/annrheumdis-2012-201706.

    Article  PubMed  Google Scholar 

  20. Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard MA, et al. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis. J Am Acad Dermatol. 2015;73(2):242–8. https://doi.org/10.1016/j.jaad.2015.05.001.

    Article  PubMed  Google Scholar 

  21. Armstrong AW, Robertson AD, Wu J, Schupp C, Lebwohl MG. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011. JAMA Dermatol. 2013;149(10):1180–5. https://doi.org/10.1001/jamadermatol.2013.5264.

    Article  CAS  PubMed  Google Scholar 

  22. • Lebwohl MG, Kavanaugh A, Armstrong AW, Van Voorhees AS. US perspectives in the Management of Psoriasis and Psoriatic Arthritis: patient and physician results from the population-based multinational assessment of psoriasis and psoriatic arthritis (MAPP) survey. Am J Clin Dermatol. 2016;17(1):87–97. https://doi.org/10.1007/s40257-015-0169-x Large study looking at the barriers to systemic medication use in psoriatic disease.

    Article  PubMed  Google Scholar 

  23. Ogdie A, Schwartzman S, Husni ME. Recognizing and managing comorbidities in psoriatic arthritis. Curr Opin Rheumatol. 2015;27(2):118–26. https://doi.org/10.1097/bor.0000000000000152.

    Article  PubMed  Google Scholar 

  24. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin. 1996;14(3):485–96.

    Article  CAS  Google Scholar 

  25. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137(3):280–4.

    CAS  PubMed  Google Scholar 

  26. Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6(6):383–92.

    Article  Google Scholar 

  27. Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41(3 Pt 1):401–7.

    Article  CAS  Google Scholar 

  28. Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol. 2010;163(3):586–92. https://doi.org/10.1111/j.1365-2133.2010.09941.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735–41. https://doi.org/10.1001/jama.296.14.1735.

    Article  CAS  PubMed  Google Scholar 

  30. Ogdie A, Yu Y, Haynes K, Love TJ, Maliha S, Jiang Y, et al. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis. 2015;74(2):326–32. https://doi.org/10.1136/annrheumdis-2014-205675.

    Article  PubMed  Google Scholar 

  31. Jamnitski A, Symmons D, Peters MJ, Sattar N, McInnes I, Nurmohamed MT. Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis. 2013;72(2):211–6. https://doi.org/10.1136/annrheumdis-2011-201194.

    Article  PubMed  Google Scholar 

  32. Horreau C, Pouplard C, Brenaut E, Barnetche T, Misery L, Cribier B, et al. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol. 2013;27(Suppl 3):12–29. https://doi.org/10.1111/jdv.12163.

    Article  PubMed  Google Scholar 

  33. Boehncke WH, Boehncke S, Schon MP. Managing comorbid disease in patients with psoriasis. BMJ. 2010;340:b5666. https://doi.org/10.1136/bmj.b5666.

    Article  PubMed  Google Scholar 

  34. Jafri K, Bartels CM, Shin D, Gelfand JM, Ogdie A. Incidence and management of cardiovascular risk factors in psoriatic arthritis and rheumatoid arthritis: a population-based study. Arthritis Care Res (Hoboken). 2017;69(1):51–7. https://doi.org/10.1002/acr.23094.

    Article  Google Scholar 

  35. Labitigan M, Bahce-Altuntas A, Kremer JM, Reed G, Greenberg JD, Jordan N, et al. Higher rates and clustering of abnormal lipids, obesity, and diabetes in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res. 2014;66(4):600–7. https://doi.org/10.1002/acr.22185.

    Article  CAS  Google Scholar 

  36. Tam LS, Tomlinson B, Chu TT, Li M, Leung YY, Kwok LW, et al. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls—the role of inflammation. Rheumatology (Oxford). 2008;47(5):718–23. https://doi.org/10.1093/rheumatology/ken090.

    Article  Google Scholar 

  37. Raychaudhuri SK, Chatterjee S, Nguyen C, Kaur M, Jialal I, Raychaudhuri SP. Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis. Metab Syndr Relat Disord. 2010;8(4):331–4. https://doi.org/10.1089/met.2009.0124.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Mok CC, Ko GT, Ho LY, Yu KL, Chan PT, To CH. Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care Res. 2011;63(2):195–202. https://doi.org/10.1002/acr.20363.

    Article  Google Scholar 

  39. Ozkan SG, Yazisiz H, Behlul A, Gokbelen YA, Borlu F, Yazisiz V. Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with psoriatic arthritis. Eur J Rheumatol. 2017;4(1):40–5. https://doi.org/10.5152/eurjrheum.2017.16052.

    Article  PubMed  PubMed Central  Google Scholar 

  40. di Minno MN, Peluso R, Iervolino S, Lupoli R, Russolillo A, Scarpa R, et al. Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis. Arthritis Care Res. 2013;65(1):141–7. https://doi.org/10.1002/acr.21711.

    Article  Google Scholar 

  41. Eder L, Thavaneswaran A, Chandran V, Cook RJ, Gladman DD. Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis. Ann Rheum Dis. 2015;74(5):813–7. https://doi.org/10.1136/annrheumdis-2013-204448.

    Article  PubMed  Google Scholar 

  42. Langan SM, Seminara NM, Shin DB, Troxel AB, Kimmel SE, Mehta NN, et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Investig Dermatol. 2012;132(3 Pt 1):556–62. https://doi.org/10.1038/jid.2011.365.

    Article  CAS  PubMed  Google Scholar 

  43. Cohen AD, Dreiher J, Birkenfeld S. Psoriasis associated with ulcerative colitis and Crohn’s disease. J Eur Acad Dermatol Venereol. 2009;23(5):561–5. https://doi.org/10.1111/j.1468-3083.2008.03031.x.

    Article  CAS  PubMed  Google Scholar 

  44. Li WQ, Han JL, Chan AT, Qureshi AA. Psoriasis, psoriatic arthritis and increased risk of incident Crohn’s disease in US women. Ann Rheum Dis. 2013;72(7):1200–5. https://doi.org/10.1136/annrheumdis-2012-202143.

    Article  PubMed  Google Scholar 

  45. Breban M. Gut microbiota and inflammatory joint diseases. Joint Bone Spine. 2016;83(6):645–9. https://doi.org/10.1016/j.jbspin.2016.04.005.

    Article  PubMed  Google Scholar 

  46. Eppinga H, Poortinga S, Thio HB, Nijsten TEC, Nuij V, van der Woude CJ, et al. Prevalence and phenotype of concurrent psoriasis and inflammatory bowel disease. Inflamm Bowel Dis. 2017;23(10):1783–9. https://doi.org/10.1097/mib.0000000000001169.

    Article  PubMed  Google Scholar 

  47. Rehal B, Modjtahedi BS, Morse LS, Schwab IR, Maibach HI. Ocular psoriasis. J Am Acad Dermatol. 2011;65(6):1202–12. https://doi.org/10.1016/j.jaad.2010.10.032.

    Article  PubMed  Google Scholar 

  48. Lambert JR, Wright V. Eye inflammation in psoriatic arthritis. Ann Rheum Dis. 1976;35(4):354–6.

    Article  CAS  Google Scholar 

  49. Rosenbaum JT. Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease. Clin Rheumatol. 2015;34(6):999–1002. https://doi.org/10.1007/s10067-015-2960-8.

    Article  PubMed  Google Scholar 

  50. Egeberg A, Khalid U, Gislason GH, Mallbris L, Skov L, Hansen PR. Association of psoriatic disease with uveitis: a Danish Nationwide cohort study. JAMA Dermatol. 2015;151(11):1200–5. https://doi.org/10.1001/jamadermatol.2015.1986.

    Article  PubMed  Google Scholar 

  51. Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146(8):891–5. https://doi.org/10.1001/archdermatol.2010.186.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Dommasch ED, Li T, Okereke OI, Li Y, Qureshi AA, Cho E. Risk of depression in women with psoriasis: a cohort study. Br J Dermatol. 2015;173(4):975–80. https://doi.org/10.1111/bjd.14032.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. McDonough E, Ayearst R, Eder L, Chandran V, Rosen CF, Thavaneswaran A, et al. Depression and anxiety in psoriatic disease: prevalence and associated factors. J Rheumatol. 2014;41(5):887–96. https://doi.org/10.3899/jrheum.130797.

    Article  PubMed  Google Scholar 

  54. Michelsen B, Kristianslund EK, Sexton J, Hammer HB, Fagerli KM, Lie E, et al. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis. 2017;76(11):1906–10. https://doi.org/10.1136/annrheumdis-2017-211284.

    Article  PubMed  Google Scholar 

  55. Horn EJ, Fox KM, Patel V, Chiou CF, Dann F, Lebwohl M. Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. J Am Acad Dermatol. 2007;57(6):957–62. https://doi.org/10.1016/j.jaad.2007.06.042.

    Article  PubMed  Google Scholar 

  56. Favier G, Gladman DD, Merola JF, Armstrong AW, Boehncke WH, Helliwell PS. Benchmarking care in psoriatic arthritis—the QUANTUM report: a report from the GRAPPA 2016 annual meeting. J Rheumatol. 2017;44(5):674–8. https://doi.org/10.3899/jrheum.170142.

    Article  PubMed  Google Scholar 

  57. Cohen JM, Husni ME, Qureshi AA, Merola JF. Psoriatic arthritis: it’s as easy as “PSA”. J Am Acad Dermatol. 2015;72(5):905–6. https://doi.org/10.1016/j.jaad.2014.12.008.

    Article  PubMed  Google Scholar 

  58. Polachek A, Li S, Chandran V, Gladman DD. Clinical enthesitis in a prospective longitudinal psoriatic arthritis cohort: incidence, prevalence, characteristics, and outcome. Arthritis Care Res (Hoboken). 2017;69(11):1685–91. https://doi.org/10.1002/acr.23174.

    Article  PubMed  Google Scholar 

  59. Spadaro A, Iagnocco A, Perrotta FM, Modesti M, Scarno A, Valesini G. Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis. Rheumatology (Oxford). 2011;50(11):2080–6. https://doi.org/10.1093/rheumatology/ker284.

    Article  Google Scholar 

  60. Sunkureddi P, Doogan S, Heid J, Benosman S, Ogdie A, Martin L, et al. Evaluation of self-reported patient experiences: insights from digital patient communities in psoriatic arthritis. J Rheumatol. 2018;45(5):638–47. https://doi.org/10.3899/jrheum.170500.

    Article  PubMed  Google Scholar 

  61. Callen JP, Krueger GG, Lebwohl M, McBurney EI, Mease P, Menter A, et al. AAD consensus statement on psoriasis therapies. J Am Acad Dermatol. 2003;49(5):897–9. https://doi.org/10.1067/S0190.

    Article  PubMed  Google Scholar 

  62. Mrowietz U, Kragballe K, Nast A, Reich K. Strategies for improving the quality of care in psoriasis with the use of treatment goals—a report on an implementation meeting. J Eur Acad Dermatol Venereol. 2011;25(Suppl 3):1–13. https://doi.org/10.1111/j.1468-3083.2011.04033.x.

    Article  PubMed  Google Scholar 

  63. Gladman DD, Thavaneswaran A, Chandran V, Cook RJ. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? Ann Rheum Dis. 2011;70(12):2152–4. https://doi.org/10.1136/ard.2011.150938.

    Article  PubMed  Google Scholar 

  64. Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74(6):1045–50. https://doi.org/10.1136/annrheumdis-2013-204858.

    Article  CAS  PubMed  Google Scholar 

  65. •• Coates LC, Moverley AR, McParland L, Brown S, Navarro-Coy N, O’Dwyer JL, et al. Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. Lancet. 2015;386(10012):2489–98. https://doi.org/10.1016/s0140-6736(15)00347-5 Important study on showing improved psoriatic arthritis outcomes in patients who are treated early and aggressively.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Storm A, Andersen SE, Benfeldt E, Serup J. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol. 2008;59(1):27–33. https://doi.org/10.1016/j.jaad.2008.03.045.

    Article  PubMed  Google Scholar 

  67. Augustin M, Alvaro-Gracia JM, Bagot M, Hillmann O, van de Kerkhof PC, Kobelt G, et al. A framework for improving the quality of care for people with psoriasis. J Eur Acad Dermatol Venereol. 2012;26(Suppl 4):1–16. https://doi.org/10.1111/j.1468-3083.2012.04576.x.

    Article  PubMed  Google Scholar 

  68. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum. 2009;61(2):233–9. https://doi.org/10.1002/art.24172.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Abuabara K, Wan J, Troxel AB, Shin DB, Van Voorhees AS, Bebo BF Jr, et al. Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis. J Am Acad Dermatol. 2013;68(2):262–9. https://doi.org/10.1016/j.jaad.2012.07.007.

    Article  PubMed  Google Scholar 

  70. Mody E, Husni ME, Schur P, Qureshi AA. Multidisciplinary evaluation of patients with psoriasis presenting with musculoskeletal pain: a dermatology: rheumatology clinic experience. Br J Dermatol. 2007;157(5):1050–1. https://doi.org/10.1111/j.1365-2133.2007.08139.x.

    Article  CAS  PubMed  Google Scholar 

  71. •• Velez NF, Wei-Passanese EX, Husni ME, Mody EA, Qureshi AA. Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic. Arch Dermatol Res. 2012;304(1):7–13. https://doi.org/10.1007/s00403-011-1172-6 Seminal study showing the effects of a combined rheumatology-dermatology clinic.

    Article  PubMed  Google Scholar 

  72. •• Okhovat JP, Ogdie A, Reddy SM, Rosen CF, Scher JU, Merola JF. Psoriasis and psoriatic arthritis clinics multicenter advancement network consortium (PPACMAN) survey: benefits and challenges of combined rheumatology-dermatology clinics. J Rheumatol. 2017;44(5):693–4. https://doi.org/10.3899/jrheum.170148 Great overview of the benefits and challenges to combined clinics.

    Article  PubMed  Google Scholar 

  73. PPACMAN. PPACMAN Mission. 2018. http://www.ppacman.org/about.html. Accessed 1 Jul 2018.

  74. Gn C, Conway D, Cunha J, Qureshi AA, Paek SY, Reginato AM. Patient outcomes from a tertiary center combined rheumatology-dermatology-clinic [abstract]. Arthritis Rheum. 2017. 69(suppl). https://acrabstracts.org/abstract/patient-outcomes-from-a-tertiary-center-combined-rheumatology-dermatology-clinic/. Accessed 1 Jul 2018.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Soumya M. Reddy.

Ethics declarations

Conflict of Interest

Dr. Reddy reports personal fees from Novartis, Pfizer, Celgene, UCB, and Abbvie outside of the submitted work.

Dr. Ogdie reports grants from Novartis and Pfizer and personal fees from Abbvie, Amgen, BMS, Celgene, Corrona, Lilly, Novartis, Pfizer, and Takeda, outside the submitted work.

Dr. Scher reports personal fees from UCB, Novartis, and Janssen, outside the submitted work.

Dr. Merola reports personal fees from Merck Research, Abbvie, Eli Lilly, Novartis, Janssen, UCB, Samumed, Celgene, Sanofi, and GSK and personal fees from Abbvie, grants from Biogen, Pfizer, Sanofi, Incyte, Aclaris, and Novartis, outside the submitted work.

Rebecca Haberman, and Lourdes M. Perez-Chada declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Rebecca Haberman and Lourdes M. Perez-Chada are co-primary authors.

This article is part of the Topical Collection on Psoriatic Arthritis

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Haberman, R., Perez-Chada, L.M., Merola, J.F. et al. Bridging the Gaps in the Care of Psoriasis and Psoriatic Arthritis: the Role of Combined Clinics. Curr Rheumatol Rep 20, 76 (2018). https://doi.org/10.1007/s11926-018-0785-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11926-018-0785-6

Keywords

Navigation